Medical/Pharmaceuticals
Artificial Intelligence to Boost the Global Wound Care Market by 2026 with Minimal Intervention Solutions
The global wound care solutions market is estimated to garner $30.5 billion in revenue by 2026 at a compound annual growth rate of 6.7%, finds Frost & Sullivan SAN ANTONIO, Oct. 18, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Global Wound Care Solutions and New-age Technology Growth ...
2021-10-18 15:03
1761
Mentice receives order of total SEK 7.0 million from ABBOTT
STOCKHOLM, Oct. 18, 2021 /PRNewswire/ -- Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, has through its fully owned subsidiary Mentice Inc entered into an agreement withABBOTT Inc. to provide simulation ...
2021-10-18 14:54
2059
Nanoform convenes EGM to elect Jeanne Thoma as board member
HELSINKI, Finland, Oct. 18, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform "), an innovative nanoparticle medicine enabling company, will convene an extraordinary general meeting (EGM) onNovember 17, 2021, at 14:00 EEST to elect Jeanne Thoma as a new board member. The notice to the EGM was p...
2021-10-18 14:06
2156
Alphamab Oncology Completed Enrollment in the First Pivotal Phase III Clinical Study of the Bispecific Antibody KN046
* ENREACH-LUNG-01 is a multi-center, randomized, double-blind, placebo-controlled phase III clinical study of KN046 combined with platinum-containing chemotherapy in patients with advanced unresectable or metastatic squamous NSCLC. Enrollment of all 482 patients has been completed according to...
2021-10-18 10:19
3226
Innovent Announces ORIENT-31, a Phase 3 Study of Sintilimab in Patients with EGFR-Mutated Nonsquamous Non-Small Cell Lung Cancer with Prior EGFR-TKI Treatment, Has Met Primary Endpoint
SAN FRANCISCO and SUZHOU, China, Oct. 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2021-10-18 08:00
5481
AFT Launches NZ-Made, 100% Natural, 90% Recyclable Hemptuary® Skincare Range
SYDNEY, Oct. 18, 2021 /PRNewswire/ -- Skincare mavens and beauty gurus have a
new product to not only feel good in but feel good about – AFT Pharmaceuticals'
new skincare range, Hemptuary®, is made inNew Zealand from 100% natural
ingredients and has packaging that is 90% recyclable.
2021-10-18 05:00
2723
Webinar on Healthcare Innovations for Sustainable Future by Kalkine Media on October 21, 2021
SYDNEY, Oct. 16, 2021 /PRNewswire/ -- Ensuring healthy lives and promoting physical and mental well-being is essential to sustainable development. Currently, the world is facing a global health crisis unlike any other. Global health has increasingly gained international visibility and prominence...
2021-10-16 06:00
4893
Novavax to Participate in World Vaccine Congress Europe
GAITHERSBURG, Md., Oct. 16, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a...
2021-10-16 04:39
5755
Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respiratory Medicine
TAIPEI, Oct. 15, 2021 /PRNewswire/ -- The Lancet Respiratory Medicine
2021-10-15 18:36
5366
Antengene to Present Data of Its PD-L1/4-1BB Bispecific Antibody ATG-101 and ERK1/2 Inhibitor ATG-017 at SITC 2021
SHANGHAI and HONG KONG, Oct. 15, 2021 /PRNewswire/ -- The 36th Annual Meeting of the Society for Immunotherapy for Cancer (SITC 2021) will take place in Washington, D.C., United States, on November 10-14, 2021. The SITC's annual meeting is the world's largest gathering in the field of immuno-oncol...
2021-10-15 13:33
3934
International Biopharma Industry Week Shanghai 2021 Opens
SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- On October 11, the International Biopharma Industry Week Shanghai 2021, under the guidance of the Shanghai Biomedical Industry Development Leading Group, the inaugural International Biopharma Industry Week Shanghai (IBIWS) is co-hosted by Shanghai Biomedica...
2021-10-15 12:22
4726
Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx
SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Abbisko (SEHK:2256), a clinical-stage biopharmaceutical company, listed on the main board of the Hong Kong Stock Exchange onOctober 13. The issue price isHK$ 12.46 per share, representing a market cap of HK$ 8.753 ...
2021-10-15 12:00
4764
Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effective Universal Booster For Vaccines Produced By AstraZeneca, Sinopharm, Moderna And Cansino Inducing Strong Immune Response And Showing High Safety Profile. Combination Of AstraZeneca And Sputnik Light Vaccines Showed High Immunogenicity Results.
* One-shot Sputnik Light is the first component of the Sputnik V vaccine, the world's first registered vaccine against coronavirus. Sputnik V pioneered the heterogeneous boosting approach (a "vaccine cocktail" using human adenovirus serotype 26 as the first component and human adenovirus seroty...
2021-10-15 05:26
2656
Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA)
BEIJING and BRIDGEWATER, N.J., Oct. 14, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), is pleased to announce the completion of two randomized, multicenter, phase 3 studies that compare proposed biosimilar Gan & Lee insulin ...
2021-10-14 20:46
4077
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms
The company's PIONEER™, EDEN™, and RAVEN™ platforms mimic the human immune system to simplify the drug development process for a range of diseases LONDON, Oct. 14, 2021 /PRNewswire/ -- Based on its recent analysis of the European AI-enabled drug discovery market,Frost & Sullivan recognizes Evaxio...
2021-10-14 19:30
2325
BioAgilytix Closes Acquisition of Australia-based 360biolabs®
Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies and development stages DURHAM, N.C., Oct. 14, 2021 /...
2021-10-14 19:00
2127
21 Swiss Startups to take the Stage at China's Hottest Tech Expos
SHANGHAI, Oct. 14, 2021 /PRNewswire/ -- 21 Swiss startups will be joining the primely-located SwissTech Pavilions at China Hi-Tech Fair fromNovember 17 - 21, 2021 in Shenzhen, and Tech G Shanghai International Consumer Electronics Show fromJanuary 13 - 15, 2022 in Shanghai. The world-class Swiss...
2021-10-14 16:18
1510
A China-developed COVID-19 vaccine is conducting clinical trial in Philippines
CHENGDU, China, Oct. 14, 2021 /PRNewswire/ -- Philippines is currently conducting, along with other countries includingIndonesia, Kenya, and Mexico, a Phase III clinical trial of Recombinant COVID-19 Vaccine (Sf9 cells) produced by WestVac Biopharma Co., LTD and National Key Laboratory of Bioth...
2021-10-14 12:58
2670
Restart-A-Heart Day - Targets Aussie Women
MELBOURNE, Australia, Oct. 14, 2021 /PRNewswire/ -- Recent studies reveal women
are 27% less likely to receive CPR in a public setting compared to men.
2021-10-14 09:15
2894
New Information from NCCN on Most Common Type of Cancer; Diagnosed in Millions Every Year
New NCCN Guidelines for Patients: Basal Cell Skin Cancer empowers patients and caregivers with knowledge about this widespread, preventable, and easily-cured cancer plus the rare subset that requires more aggressive treatment. PLYMOUTH MEETING, Pa., Oct. 13, 2021 /PRNewswire/ -- The National Com...
2021-10-13 22:07
3997
Week's Top Stories
Most Reposted
Carro secures strategic investment from Orico
[Picked up by 290 media titles]
2026-09-18 16:29Agoda Begins Limited Public Beta of New AI Assistant That Turns Travel Ideas into Bookable Trips
[Picked up by 289 media titles]
2026-09-15 11:00
Avnet and The University of Hong Kong Open EMUS Lab to Accelerate AI Innovation and Commercialization in Hong Kong
[Picked up by 281 media titles]
2026-09-17 13:09
Tetra Pak and Soy Excellence Center Asia Host Regional Soy Food and Beverage Programme in Thailand
[Picked up by 268 media titles]
2026-09-18 11:51
Sovereign Investment Institutions Launch China-ASEAN Joint Investment Council
[Picked up by 267 media titles]
2026-09-16 09:09
Most Read
Agoda Begins Limited Public Beta of New AI Assistant That Turns Travel Ideas into Bookable Trips
2026-09-15 11:00
7923
QIVIKA to Launch Smart Scope on Kickstarter, Bringing a Professional Long-Range Experience to Day-and-Night Exploration
2026-09-12 09:00
7277
Temporal Raises $550 Million in Series E Round: NYSE Content Update
2026-09-14 21:14
6288
